Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis

NCT00439647 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1199

Enrollment

INDUSTRY

Sponsor class

Conditions

Male Osteoporosis

Interventions

DRUG: Zoledronic acid 5 mg iv
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals